All In MedTech

Device Trial Radar · NCT00909870

Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers

A Prospective, Multi-Center, Randomized, Controlled Clinical Investigation of Dermagraft(R) in Subjects With Venous Leg Ulcers DEVO-Trial

Last checked: Nov 20, 2026Latest source record: Jun 18, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingTitle says "pivotal". Randomized with 537 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

537

Actual

Start

Jun 2009

Primary completion

May 2011

Study completion Aug 2011

Sponsor

Lead sponsor
OrganogenesisNot on our public-company list
Sponsor type
Industry
First posted
May 29, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study randomly assigns patients with venous leg ulcers to receive standard therapy (compression) alone or compression plus Dermagraft(R). Dermagraft is a device containing live human fibroblasts grown on an absorbable Vicryl mesh. Patients are seen weekly until they heal or the 16-week treatment period is complete. Follow-up visits are conducted monthly for three months in order to assess patients for longer term safety.

Conditions

  • Venous Leg Ulcer

Interventions

  • Dermagraft(R)Device

    Weekly application of Dermagraft(R) with Profore compression as a secondary layer, in combination with systematic surgical wound debridement.

  • ProforeDevice

    Weekly application of Profore compression dressings, in combination with systematic surgical wound debridement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete Healing of the Study Ulcer by Week 16.Time frame: 16 weeks

Locations

70 sites in 8 countries. Site status is shown where the registry gives one.

  • Coastal Clinical Research, Inc.

    Mobile, Alabama

  • Carl T. Hayden VA Medical Center

    Phoenix, Arizona

  • HOPE Research Institute

    Phoenix, Arizona

67 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.